CD320
Basic information
Region (hg38): 19:8302127-8308358
Links
Phenotypes
GenCC
Source:
- methylmalonic acidemia due to transcobalamin receptor defect (Limited), mode of inheritance: AR
- methylmalonic acidemia due to transcobalamin receptor defect (Supportive), mode of inheritance: AR
- methylmalonic acidemia due to transcobalamin receptor defect (Limited), mode of inheritance: Unknown
- methylmalonic acidemia due to transcobalamin receptor defect (Limited), mode of inheritance: Unknown
- methylmalonic acidemia due to transcobalamin receptor defect (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methylmalonic aciduria, transient, due to transcobalamin receptor defect | AR | Biochemical; Ophthalmologic | Medical treatment (eg, with IV B6 and IM B12-hydroxocobalamine) has been shown to positively affect laboratory parameters, and may be clinically beneficial though long-term clinical sequelae are unclear | Biochemical; Ophthalmologic | 20524213; 22819238 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD320 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 37 | ||||
missense | 59 | 69 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 1 | 5 | |||
non coding | 12 | 33 | 45 | |||
Total | 0 | 0 | 68 | 48 | 43 |
Variants in CD320
This is a list of pathogenic ClinVar variants found in the CD320 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-8302274-C-T | Benign (Jul 31, 2018) | |||
19-8302334-G-A | Benign (Nov 16, 2018) | |||
19-8302380-G-C | Benign (May 25, 2021) | |||
19-8302472-C-T | Methylmalonic acidemia due to transcobalamin receptor defect | Benign/Likely benign (Sep 07, 2022) | ||
19-8302473-G-A | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Aug 19, 2022) | ||
19-8302475-G-C | not specified • Methylmalonic acidemia due to transcobalamin receptor defect | Benign (Jan 28, 2024) | ||
19-8302512-G-A | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Dec 25, 2023) | ||
19-8302523-C-T | CD320-related disorder | Likely benign (Jun 27, 2019) | ||
19-8302533-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
19-8302539-C-T | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Jul 10, 2023) | ||
19-8302540-G-A | not specified • Methylmalonic acidemia due to transcobalamin receptor defect | Benign (Dec 22, 2023) | ||
19-8302543-C-T | Methylmalonic acidemia due to transcobalamin receptor defect | Benign/Likely benign (Jan 26, 2024) | ||
19-8302551-C-T | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Sep 13, 2022) | ||
19-8302552-G-A | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Jul 12, 2022) | ||
19-8302552-G-T | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Feb 22, 2022) | ||
19-8302553-G-A | not specified • Methylmalonic acidemia due to transcobalamin receptor defect | Benign/Likely benign (Sep 23, 2023) | ||
19-8302567-G-A | Methylmalonic acidemia due to transcobalamin receptor defect • CD320-related disorder | Likely benign (Nov 07, 2023) | ||
19-8302581-G-A | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Oct 13, 2023) | ||
19-8302590-C-T | Methylmalonic acidemia due to transcobalamin receptor defect | Likely benign (Jul 07, 2023) | ||
19-8302604-C-A | Methylmalonic acidemia due to transcobalamin receptor defect | Likely benign (Feb 03, 2022) | ||
19-8302604-C-T | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Feb 24, 2020) | ||
19-8302605-G-A | not specified | Likely benign (Apr 25, 2023) | ||
19-8302620-T-A | not specified • Methylmalonic acidemia due to transcobalamin receptor defect | Benign (Feb 01, 2024) | ||
19-8302641-G-C | Benign (Aug 10, 2018) | |||
19-8302798-A-G | Methylmalonic acidemia due to transcobalamin receptor defect | Uncertain significance (Oct 14, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD320 | protein_coding | protein_coding | ENST00000301458 | 5 | 6230 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00352 | 0.851 | 125668 | 0 | 19 | 125687 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.244 | 160 | 169 | 0.947 | 0.0000101 | 1730 |
Missense in Polyphen | 34 | 46.037 | 0.73854 | 493 | ||
Synonymous | -0.528 | 82 | 76.1 | 1.08 | 0.00000511 | 610 |
Loss of Function | 1.22 | 5 | 8.93 | 0.560 | 3.81e-7 | 101 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000600 | 0.000598 |
Finnish | 0.0000495 | 0.0000462 |
European (Non-Finnish) | 0.0000367 | 0.0000352 |
Middle Eastern | 0.000600 | 0.000598 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for transcobalamin saturated with cobalamin (TCbl) (PubMed:18779389). Plays an important role in cobalamin uptake (PubMed:18779389, PubMed:20524213). Plasma membrane protein that is expressed on follicular dendritic cells (FDC) and mediates interaction with germinal center B cells (PubMed:10727470). Functions as costimulator to promote B cell responses to antigenic stimuli; promotes B cell differentiation and proliferation (PubMed:10727470, PubMed:11418631). Germinal center-B (GC-B) cells differentiate into memory B-cells and plasma cells (PC) through interaction with T-cells and follicular dendritic cells (FDC) (PubMed:11418631). CD320 augments the proliferation of PC precursors generated by IL-10 (PubMed:11418631). {ECO:0000269|PubMed:10727470, ECO:0000269|PubMed:11418631, ECO:0000269|PubMed:18779389, ECO:0000269|PubMed:20524213}.;
- Pathway
- Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.191
Intolerance Scores
- loftool
- 0.125
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.0540
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.392
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.614
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd320
- Phenotype
- hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; immune system phenotype; vision/eye phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cobalamin metabolic process;regulation of signaling receptor activity;cobalamin transport;regulation of vitamin metabolic process;positive regulation of B cell proliferation;B cell costimulation
- Cellular component
- endoplasmic reticulum;plasma membrane;integral component of plasma membrane;endosome membrane;membrane
- Molecular function
- calcium ion binding;protein binding;growth factor activity;cobalamin-transporting ATPase activity;cobalamin binding